Lincoln Pharmaceuticals consolidated Q3FY22 profit slides QoQ to Rs. 17.60 crores

Lincoln Pharmaceuticals Limited has reported Consolidated financial results for the period ended December 31, 2021.

Financial Results (Q3 FY2022) - QoQ Comparison

The company has reported total income of Rs. 122.5157 crores during the period ended December 31, 2021 as compared to Rs. 130.9281 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs. 17.6085 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 23.0245 crores for the period ended September 30, 2021.

The company has reported EPS of Rs. 8.79 for the period ended December 31, 2021 as compared to Rs. 11.50 for the period ended September 30, 2021.

Financials	Q3 FY2022	Q2 FY2022	% Change
Total Income	₹ 122.5157 crs	₹130.9281 crs	-6.43%
Net Profit	₹17.6085 crs	₹23.0245 crs	-23.52%
EPS	₹8.79	₹11.50	-23.57%

Financial Results (Q3 FY2022) - YoY Comparison

The company has reported total income of Rs. 122.5157 crores during the period ended December 31, 2021 as compared to Rs.115.4763 crores during the period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.17.6085 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.13.4818 crores for the period ended December 31, 2020.

The company has reported EPS of Rs.8.79 for the period ended December 31, 2021 as compared to Rs.6.73 for the period ended December 31, 2020.

Financials	Q3 FY2022	Q3 FY2021	% Change
Total Income	₹ 122.5157 crs	₹115.4763 crs	6.10%
Net Profit	₹17.6085 crs	₹13.4818 crs	30.61%
EPS	₹8.79	₹6.73	30.61%

Financial Results (9 Months Ended FY2022) - YoY Comparison

The company has reported total income of Rs.377.6434 crores during the 9 Months period ended December 31, 2021 as compared to Rs.347.7340 crores during the 9 Months period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.58.3313 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.49.6511 crores for the 9 Months period ended December 31, 2020.

The company has reported EPS of Rs.29.12 for the 9 Months period ended December 31, 2021 as compared to Rs.24.79 for the 9 Months period ended December 31, 2020.

Financials	9 Months Ended FY2022	9 Months Ended FY2021	% Change
Total Income	₹377.6434 crs	₹347.7340 crs	8.60%
Net Profit	₹58.3313 crs	₹49.6511 crs	17.48%
EPS	₹29.12	₹24.79	17.47%

Shares of Lincoln Pharmaceuticals Limited was last trading in BSE at Rs. 338.40 as compared to the previous close of Rs. 336.75. The total number of shares traded during the day was 16148 in over 1141 trades.

The stock hit an intraday high of Rs. 342.95 and intraday low of 334.30. The net turnover during the day was Rs. 5459545.00.

Source : Equity Bulls

Keywords

LincolnPharmaceuticals Q3FY22 9MFY22 ResultUpdate